Detalles de la búsqueda
1.
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥â¯60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023.
Euro Surveill
; 29(3)2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240061
2.
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Euro Surveill
; 29(13)2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38551095
3.
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.
Euro Surveill
; 29(8)2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38390651
4.
Organizational development and management factors involved in the prevention and effective therapy of pressure ulcers: The results of the national survey conducted among Hungarian public hospitals.
Int Wound J
; 21(1): e14655, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38272822
5.
[Cost-effectiveness of oral cancer screening in Hungary]. / A szájüregi szurés költséghatékonysága Magyarországon.
Orv Hetil
; 157(29): 1161-70, 2016 Jul.
Artículo
en Húngaro
| MEDLINE | ID: mdl-27426465
6.
Vaccine Effectiveness against GP-Attended Symptomatic COVID-19 and Hybrid Immunity among Adults in Hungary during the 2022-2023 Respiratory Season Dominated by Different SARS-CoV-2 Omicron Subvariants.
Vaccines (Basel)
; 12(5)2024 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38793747
7.
Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
Vaccine
; 42(16): 3547-3554, 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704257
8.
Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024.
Vaccine
; 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38839521
9.
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Influenza Other Respir Viruses
; 18(1): e13243, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38204584
10.
Challenges and opportunities for improvement in the management and financing system of Health Promotion Offices in Hungary.
Front Public Health
; 11: 1219186, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37965520
11.
International practices in health technology assessment and public financing of digital health technologies: recommendations for Hungary.
Front Public Health
; 11: 1197949, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37719722
12.
Riding the Pandemic Waves-Lessons to Be Learned from the COVID-19 Crisis Management in Romania.
Trop Med Infect Dis
; 7(7)2022 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35878134
13.
Real-Time Monitoring of the Effectiveness of Six COVID-19 Vaccines against Laboratory-Confirmed COVID-19 in Hungary in 2021 Using the Screening Method.
Vaccines (Basel)
; 10(11)2022 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36366334
14.
Characteristics of the Third COVID-19 Pandemic Wave with Special Focus on Socioeconomic Inequalities in Morbidity, Mortality and the Uptake of COVID-19 Vaccination in Hungary.
J Pers Med
; 12(3)2022 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35330387
15.
Experiences and Lessons Learned from COVID-19 Pandemic Management in South Korea and the V4 Countries.
Trop Med Infect Dis
; 6(4)2021 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34941657
Resultados
1 -
15
de 15
1
Próxima >
>>